The environmental release and fate of antibiotics

Marine Pollution Bulletin

Volumn 79, Issue 1-2, 2014, Pages 7-15

  Manzetti, Sergio ^a,b   Ghisi, Rossella ^c  

^a Fjordforsk AS Midtun   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Accumulation; Antibiotics; Environment; Fate; Release; Transformation

Indexed keywords

ACCUMULATION; ANTIBIOTICS; ENVIRONMENT; FATE; RELEASE; TRANSFORMATION;

ANTI-BACTERIAL AGENTS; BIODEGRADATION, ENVIRONMENTAL; ENVIRONMENTAL MONITORING; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84893859762     PISSN: 0025326X     EISSN: 18793363     Source Type: Journal    
DOI: 10.1016/j.marpolbul.2014.01.005     Document Type: Review

References (99)

1. Alnouti Y. Bile acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol. Sci. 2009, 108(2):225-246.
2. Ashton D., Hilton M., et al. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333(1):167-184.
3. Batt A.L., Bruce I.B., et al. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ. Pollut. 2006, 142(2):295-302.
4. Batt A.L., Kim S., et al. Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere 2007, 68(3):428-435.
5. Berger K., Petersen B., et al. Persistenz von Gülle-Arzneistoffen in der Nahrungskette. Arch. Lebensmittelhyg 1986, 37:85-108.
6. Bertault-Peres P., Bonfils C., et al. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metab. Dispos. 1987, 15(3):391-398.
7. Bound J.P., Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ. Health Perspect. 2005, 113(12):1705.
8. Brown K.D., Kulis J., et al. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 2006, 366(2):772-783.
9. Cabello F.C. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ. Microbiol. 2006, 8(7):1137-1144.
10. Calamari D., Zuccato E., et al. Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ. Sci. Technol. 2003, 37(7):1241-1248.
11. Chahine S., O'Donnell M.J. Interactions between detoxification mechanisms and excretion in Malpighian tubules of Drosophila melanogaster. J. Exp. Biol. 2011, 214(3):462-468.
12. Chang H., Hu J., et al. Simultaneous analysis of 16 sulfonamide and trimethoprim antibiotics in environmental waters by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2008, 1190(1-2):390-393.
13. Cooper K., Mulder P.J., et al. Depletion of four nitrofuran antibiotics and their tissue-bound metabolites in porcine tissues and determination using LC-MS/MS and HPLC-UV. Food Addit. Contam. 2005, 22(5):406-414.
14. Costanzo S.D., Murby J., et al. Ecosystem response to antibiotics entering the aquatic environment. Mar. Pollut. Bull. 2005, 51(1):218-223.
15. De Liguoro M., Cibin V., et al. Use of oxytetracycline and tylosin in intensive calf farming: evaluation of transfer to manure and soil. Chemosphere 2003, 52(1):203-212.
16. de Montellano P.R.O. Cytochrome P450: Structure, Mechanism, and Biochemistry 2005, Springer.
17. *. Annu. Rev. Pharmacol. Toxicol. 2003, 43(1):309-334.
18. Desta Z., Ward B.A., et al. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J. Pharmacol. Exp. Ther. 2004, 310(3):1062-1075.
19. Díaz-Cruz M.S., García-Galán M.J., et al. Highly sensitive simultaneous determination of sulfonamide antibiotics and one metabolite in environmental waters by liquid chromatography-quadrupole linear ion trap-mass spectrometry. J. Chromatogr. A 2008, 1193(1):50-59.
20. Donoghue D.J. Antibiotic residues in poultry tissues and eggs: human health concerns?. Poult. Sci. 2003, 82(4):618-621.
21. ECDPC, 2010. Surveillance of Antimicrobial Consumption in Europe, 2010. ECDC, 2013. doi:10.2900/76806.
22. EMA, 2011. Trends in the Sales of Veterinary Antimicrobial Agents in nine European Countries (2005-2009) (EMA/238630/2011).
23. EMA, 2012. Sales of Veterinary Antimicrobial Agents in 19 EU/EEA Countries in 2010 (EMA/88728/2012).
24. Eum K.-D., Wang F.T., et al. Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function. Neurotoxicology 2013.
25. Farkas M.H., Berry J.O., et al. Chlortetracycline detoxification in maize via induction of glutathione S-transferases after antibiotic exposure. Environ. Sci. Technol. 2007, 41(4):1450-1456.
26. FDA, 1998. Guidance for Industry-Environmental Assessment of Human Drugs and Biologics Applications, Revision 1. Centre for Drug Evaluation and Research.
27. FEDESA, 2001. Antibiotic Use in Farm Animals does not Threaten Human Health. FEDESA/FEFANA Press release, 13 July (Brussels, Belgium).
28. Ferguson J., Baxter A., et al. Detection of chloramphenicol and chloramphenicol glucuronide residues in poultry muscle, honey, prawn and milk using a surface plasmon resonance biosensor and Qflex® kit chloramphenicol. Anal. Chim. Acta 2005, 529(1):109-113.
29. Fleming A. The discovery of penicillin. Br. Med. Bull. 1944, 2(1):4-5.
30. Fleming, A., 1946. Penicillin. Its Practical Application.
31. Focazio M.J., Kolpin D.W., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States-II) Untreated drinking water sources. Sci. Total Environ. 2008, 402(2):201-216.
32. García-Galán M.J., Silvia Díaz-Cruz M., et al. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. TrAC, Trends Anal. Chem. 2008, 27(11):1008-1022.
33. Garteiz D., Hook R., et al. Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneimittelforschung 1982, 32(9a):1185.
34. Giamarellos-Bourboulis E., Grecka P., et al. In vitro interactions of γ-Linolenic acid and arachidonic acid with ceftazidime on multiresistant Pseudomonas aeruginosa. Lipids 1999, 34:S151-S152.
35. Glassmeyer S.T., Furlong E.T., et al. Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ. Sci. Technol. 2005, 39(14):5157-5169.
36. Gulkowska A., He Y., et al. The occurrence of selected antibiotics in Hong Kong coastal waters. Mar. Pollut. Bull. 2007, 54(8):1287-1293.
37. Göbel A., McArdell C.S., et al. Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry. Anal. Chem. 2004, 76(16):4756-4764.
38. Haller M.Y., Müller S.R., et al. Quantification of veterinary antibiotics (sulfonamides and trimethoprim) in animal manure by liquid chromatography-mass spectrometry. J. Chromatogr. A 2002, 952(1):111-120.
39. Halling-Sørensen B., Nors Nielsen S., et al. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-393.
40. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35(1):307-340.
41. Hirsch R., Ternes T., et al. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225(1):109-118.
42. Hu, Z., 2013. Adsorption Removal of Tetracycline from Aqueous Solution by Anaerobic Granular Sludge: Equilibrium and Kinetic Studies.
43. Jiang M., Wang L., et al. Biotic and abiotic degradation of four cephalosporin antibiotics in a lake surface water and sediment. Chemosphere 2010, 80(11):1399-1405.
44. Jurima-Romet M., Crawford K., et al. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab. Dispos. 1994, 22(6):849-857.
45. Kafafi S.A., Afeefy H.Y., et al. Relationship between aryl hydrocarbon receptor binding, induction of aryl hydrocarbon hydroxylase and 7-ethoxyresorufin O-deethylase enzymes, and toxic activities of aromatic xenobiotics in animals. A new model. Chem. Res. Toxicol. 1993, 6(3):328-334.
46. Karthikeyan K., Meyer M.T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Sci. Total Environ. 2006, 361(1):196-207.
47. Kemper N. Veterinary antibiotics in the aquatic and terrestrial environment. Ecol. Ind. 2008, 8(1):1-13.
48. Kennedy K.A., Rockwell S., et al. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res. 1980, 40(7):2356-2360.
49. Kimura K., Toshima S., et al. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci. 2004, 245(1):71-78.
50. Kingston W. Irish contributions to the origins of antibiotics. Ir. J. Med. Sci. 2008, 177(2):87-92.
51. Kolpin D.W., Furlong E.T., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36(6):1202-1211.
52. Kropp H., Sundelof J.G., et al. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase-I. Antimicrob. Agents Chemother. 1982, 22(1):62-70.
53. Kumar K., Gupta S.C., et al. Antibiotic use in agriculture and its impact on the terrestrial environment. Adv. Agron. 2005, 87:1-54.
54. Kumar K., Thompson A., et al. Enzyme-linked immunosorbent assay for ultratrace determination of antibiotics in aqueous samples. J. Environ. Qual. 2004, 33(1):250-256.
55. Kümmerer K. Significance of antibiotics in the environment. J. Antimicrob. Chemother. 2003, 52(1):5-7.
56. Kümmerer K., Al-Ahmad A., et al. Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 2000, 40(7):701-710.
57. Lalumera G.M., Calamari D., et al. Preliminary investigation on the environmental occurrence and effects of antibiotics used in aquaculture in Italy. Chemosphere 2004, 54(5):661-668.
58. Landsberg H. Prelude to the discovery of penicillin. Isis 1949, 40(3):225-227.
59. Larsson D., de Pedro C., et al. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148(3):751-755.
60. Leitner A., Zöllner P., et al. Determination of the metabolites of nitrofuran antibiotics in animal tissue by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2001, 939(1):49-58.
61. Lin A.Y.-C., Tsai Y.-T. Occurrence of pharmaceuticals in Taiwan's surface waters: Impact of waste streams from hospitals and pharmaceutical production facilities. Sci. Total Environ. 2009, 407(12):3793-3802.
62. Llor C., Bjerrum L. Background for different use of antibiotics in different countries. Clin. Infect. Dis. 2005, 40(2):333.
63. Loos R., Locoro G., et al. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res. 2010, 44(14):4115-4126.
64. Luo Y., Xu L., et al. Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River Basin, China. Environ. Sci. Technol. 2011, 45(5):1827-1833.
65. Manzetti S., Stenersen J.H.V. A critical view of the environmental condition of the Sognefjord. Mar. Pollut. Bull. 2010, 60(12):2167-2174.
66. McCracken R.J., Kennedy D.G. The bioavailability of residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations. Food Addit. Contam. 1997, 14(5):507-513.
67. Metcalfe C.D., Miao X.S., et al. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 2003, 22(12):2881-2889.
68. Palma B.B., e Sousa M.S, et al. Functional characterization of eight human CYP1A2 variants: the role of cytochrome b5. Pharmacogenet. Genomics 2013, 23(2):41-52.
69. Patrick D.M., Marra F., et al. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?. Clin. Infect. Dis. 2004, 39(1):11-17.
70. Rabølle M., Spliid N.H. Sorption and mobility of metronidazole, olaquindox, oxytetracycline and tylosin in soil. Chemosphere 2000, 40(7):715-722.
71. Renew J.E., Huang C.-H. Simultaneous determination of fluoroquinolone, sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase extraction and liquid chromatography-electrospray mass spectrometry. J. Chromatogr. A 2004, 1042(1):113-121.
72. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356(1):143-153.
73. Roldan A., Torres-Rivera A., et al. Structural and biochemical studies of a recombinant 25.5 kDa glutathione transferase of Taenia solium metacestode (rTs25GST1-1). Parasitol. Res. 2013, 1-8.
74. Sacher F., Lange F.T., et al. Pharmaceuticals in groundwaters: analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J. Chromatogr. A 2001, 938(1):199-210.
75. Sasabe H., Tsuji A., et al. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. J. Pharmacol. Exp. Ther. 1998, 284(3):1033-1039.
76. Schaider L.A., Rudel R.A., et al. Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer. Sci. Total Environ. 2014, 468-469:384-393.
77. Stackelberg P.E., Furlong E.T., et al. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 2004, 329(1):99-113.
78. Stiborova M., Cechova T., et al. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes. Neuro Endocrinol. Lett. 2012, 33(Suppl3):8-15.
79. Sukul P., Spiteller M. Sulfonamides in the environment as veterinary drugs. Reviews of environmental contamination and toxicology 2006, Springer, pp. 67-101.
80. Sullivan H.R., Due S.L., et al. Metabolism of [14C] cefaclor, a cephalosporin antibiotic, in three species of laboratory animals. Antimicrob. Agents Chemother. 1976, 10(4):630-638.
81. Terrier P., Townsend A.J., et al. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 1990, 137(4):845.
82. Thiele-Bruhn S. Pharmaceutical antibiotic compounds in soils - a review. J. Plant Nutr. Soil Sci. 2003, 166(2):145-167.
83. Thomas J.H. Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet. 2007, 3(5):e67.
84. Unzeta M., Sole M., et al. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J. Neural Transm. 2007, 114(6):857-862.
85. Vander Stichele R., Elseviers M.M., et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J. Antimicrob. Chemother. 2006, 58(1):159-167.
86. Vree T., de Ven E., et al. Isolation, identification and determination of sulfadiazine and its hydroxy metabolites and conjugates from man and Rhesus monkey by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1995, 670(1):111-123.
87. Vyskočilová E., Szotáková B., et al. Age-related changes in hepatic activity and expression of detoxification enzymes in male rats. BioMed Res. Int. 2013.
88. Wallace R.J. Antimicrobial properties of plant secondary metabolites. Proc. Nutr. Soc. 2004, 63(04):621-629.
89. Wang L., Ying G.-G., et al. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci. Total Environ. 2010, 408(16):3139-3147.
90. Watkinson A., Murby E., et al. The occurrence of antibiotics in an urban watershed: from wastewater to drinking water. Sci. Total Environ. 2009, 407(8):2711-2723.
91. Weber C., Wider G., et al. NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. Biochemistry 1991, 30(26):6563-6574.
92. Xu W.-H., Zhang G., et al. Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Environ. Pollut. 2007, 145(3):672-679.
93. Xu W., Zhang G., et al. A preliminary investigation on the occurrence and distribution of antibiotics in the Yellow River and its tributaries, China. Water Environ. Res. 2009, 81(3):248-254.
94. Yamamura N., Imura-Miyoshi K., et al. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats. Drug Metab. Dispos. 2000, 28(12):1484-1486.
95. Yoon Y., Westerhoff P., et al. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membr. Sci. 2006, 270(1):88-100.
96. Yu P., Zuo D. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 1993, 42(4):594-603.
97. Yu P.H., Wright S., et al. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim. Biophys. Acta (BBA) - Proteins Proteomics 2003, 1647(1):193-199.
98. Zhang Y., Geißen S.-U., et al. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73(8):1151-1161.
99. Zuccato E., Castiglioni S., et al. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J. Hazard. Mater. 2005, 122(3):205-209.